The Indian government intends to lower the cost of the HPV vaccine, aimed at girls between the ages of 9 and 14, in an effort to prevent cervical cancer. This project was disclosed by Finance Minister Nirmala Sitharaman at the presentation of the Interim Budget 2024.
Cost-effectiveness of Expanding Vaccination
The government is in talks with Serum Institute of India (SII), one of the top domestic vaccine producers, to make the vaccine available. The two doses currently retail for about Rs 2,000 apiece, thus the price drop is essential for increasing immunization rates.
Startling Statistics on Cervical Cancer
Cervical cancer poses a serious hazard to India’s 511.4 million women who are 15 and older. Initiated by specific strains of Human Papillomavirus (HPV), this program attempts to target the high-risk population susceptible to the disease.
Cervical cancer can result from HPV, a family of 200 related viruses, especially from high-risk varieties. Almost everyone who engages in sexual activity has the potential to contract HPV, a sexually transmitted infection, at some point. Persistent infections can increase the risk of cervical cancer even though the majority of infections resolve on their own.
Perspective on Global Health and Vaccines
This action, which emphasizes vaccination as a preventative measure, is in line with international efforts to fight cervical cancer. The World Health Organization emphasizes how common HPV infections are and how crucial preventative actions are to lowering the global incidence of cervical cancer.
You can also join our Facebook Community
You can also read about Sultan Ibrahim
You can also check out our YouTube channel
[…] You can also read about Cervical Cancer […]
[…] You can also read about Cervical cancer Vaccine […]